United Ecoenergy Corp. (UEEC) 0.1190 $UEEC
United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd
Business Wire - Fri Feb 21, 7:31AM CST
United Health Products, Inc. (OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate, COO, will present at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference on Monday, March 3rd, at 12:50pm EST, at The University Club of New York.
United Health Products Inc. Receives Initial HemoStyp(R) Order for Australian Market
Business Wire - Thu Dec 19, 7:31AM CST
United Health Products, Inc. (OTCQB:UEEC) announced that its Australian distributor, Critical Health Products Ltd., has placed an initial order for HemoStyp(R) gauze products. The order was placed following Critical Health Products' notification that HemoStyp has been granted TGA (Therapeutic Goods Administration) approval. The TGA is a Commonwealth Government agency that regulates medical devices and drugs in Australia.
United Health Products Inc. to Present at 6th Annual LD MICRO Conference on December 3rd
Business Wire - Wed Nov 27, 7:32AM CST
United Health Products, Inc. (OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate will present at the Sixth Annual LD MICRO Conference on Tuesday, December 3rd, at 1:00 p.m. PST, at the Luxe Hotel Sunset Boulevard in Los Angeles.
United Health Products Receives Notice of Allowance for Patent Application for HemoStyp(TM) Gauze Product - Anticipates First Orders from Dental and Medical Markets
Business Wire - Mon Sep 16, 7:34AM CDT
United Health Products, Inc. (OTCQB: UEEC) announced that it has received formal notification of allowance of its patent application from the U.S. Patent Office for its hemostatic gauze product, HemoStyp(TM), and that the patent will issue shortly. The Company is also pursuing additional applications and filings for its HemoStyp product line.
United Health Products, Inc. Initiates Investor Relations
Business Wire - Thu Jul 18, 7:24AM CDT
United Health Products, Inc. (OTCQB: UEEC) announced today that it has engaged Bibicoff + MacInnis, Inc., a full service investor relations and strategic planning firm, to increase investment community awareness of the Company. Bibicoff + MacInnis will initially concentrate on developing and implementing communications strategies and programs specifically targeting the retail brokerage, institutional and investment banking communities.
United Health Products Inc. Recognized as a Vendor Supplier to the Church of Jesus Christ of Latter Day Saints, and Receives Order for HemoStyp(TM) Gauze
Business Wire - Thu Mar 07, 8:30AM CST
United Health Products, Inc. www.unitedhealthproductsinc.com (OTCQB: UEEC.PK) wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector has been recognized as a vendor/supplier by the Church of Jesus Christ of Latter Day Saints (LDS). United Health Products has provided LDS with initial orders of its HemoStyp(TM) Gauze that is being incorporated into aid packages for Humanitarian Relief and Assistance.
United Health Products Inc.'s Epic Wound Care Inc. Announces Agreement with Ryan Network for Beta Test of United's HemoStyp(TM) Wound Care Product
Business Wire - Thu Feb 14, 9:30AM CST
United Health Products, Inc.'s www.unitedhealthproductsinc.com (OTCQB: UEEC.PK) wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp(TM). Under the beta test protocol, the HemoStyp(TM) gauze will be indicated for patients post venipuncture to assess expedited coagulation, ease of use, patient satisfaction, and decrease prolonged coagulation due to patients co-morbidities and anticoagulation therapy. The Ryan Network was founded upon former Congressman William F. Ryan's belief that "health care is a right, not a privilege." Ryan Network is a family of not-for-profit, federally qualified health centers with multiple locations in New York Ci
United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp(TM) Featured in Dentistry Today
Business Wire - Tue Jan 22, 10:43AM CST
United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp(TM), has been featured in the January 2013 edition of Dentistry Today. The article states that while there are other "hemostatic agents available to the dental practitioner, most of them are difficult to place, difficult to keep in position, and difficult to remove without disturbing the clotted surface, thereby reinitiating the bleeding. This specifically formulated gauze produces hemostasis almost instantly when positioned on a cut or wound. It contains no potentially harmful chemicals such as thrombin, collagen, or animal byproducts, is hypoallergenic, and works more quickly than other hemostatic agents. Once i
United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp(TM) Listed by Industry Publication Among the "Best Products Evaluated During 2012"; United Health Products Adds New Member to Board of Directors
Business Wire - Wed Dec 19, 12:21PM CST
United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp(TM), has been featured in the Clinicians Report(R) for the second time this year. The report is a published scientific testimonial that features products which have met the criteria and approval of the dental community. The Clinicians Report(R) is a 35-year-old industry publication serving as an informative tool to the dental industry with distribution to over 10,000 dental care providers. It features new products with published test results that have been tested and approved by dentists and the dental community. In the December issue HemoStyp(TM) was listed among the "Best Products Evaluated During 2012" with 83%
United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd
Business Wire - Fri Feb 21, 7:31AM CST
United Health Products, Inc. (OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate, COO, will present at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference on Monday, March 3rd, at 12:50pm EST, at The University Club of New York.
United Health Products Inc. Receives Initial HemoStyp(R) Order for Australian Market
Business Wire - Thu Dec 19, 7:31AM CST
United Health Products, Inc. (OTCQB:UEEC) announced that its Australian distributor, Critical Health Products Ltd., has placed an initial order for HemoStyp(R) gauze products. The order was placed following Critical Health Products' notification that HemoStyp has been granted TGA (Therapeutic Goods Administration) approval. The TGA is a Commonwealth Government agency that regulates medical devices and drugs in Australia.
United Health Products Inc. to Present at 6th Annual LD MICRO Conference on December 3rd
Business Wire - Wed Nov 27, 7:32AM CST
United Health Products, Inc. (OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate will present at the Sixth Annual LD MICRO Conference on Tuesday, December 3rd, at 1:00 p.m. PST, at the Luxe Hotel Sunset Boulevard in Los Angeles.
United Health Products Receives Notice of Allowance for Patent Application for HemoStyp(TM) Gauze Product - Anticipates First Orders from Dental and Medical Markets
Business Wire - Mon Sep 16, 7:34AM CDT
United Health Products, Inc. (OTCQB: UEEC) announced that it has received formal notification of allowance of its patent application from the U.S. Patent Office for its hemostatic gauze product, HemoStyp(TM), and that the patent will issue shortly. The Company is also pursuing additional applications and filings for its HemoStyp product line.
United Health Products, Inc. Initiates Investor Relations
Business Wire - Thu Jul 18, 7:24AM CDT
United Health Products, Inc. (OTCQB: UEEC) announced today that it has engaged Bibicoff + MacInnis, Inc., a full service investor relations and strategic planning firm, to increase investment community awareness of the Company. Bibicoff + MacInnis will initially concentrate on developing and implementing communications strategies and programs specifically targeting the retail brokerage, institutional and investment banking communities.
United Health Products Inc. Recognized as a Vendor Supplier to the Church of Jesus Christ of Latter Day Saints, and Receives Order for HemoStyp(TM) Gauze
Business Wire - Thu Mar 07, 8:30AM CST
United Health Products, Inc. www.unitedhealthproductsinc.com (OTCQB: UEEC.PK) wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector has been recognized as a vendor/supplier by the Church of Jesus Christ of Latter Day Saints (LDS). United Health Products has provided LDS with initial orders of its HemoStyp(TM) Gauze that is being incorporated into aid packages for Humanitarian Relief and Assistance.
United Health Products Inc.'s Epic Wound Care Inc. Announces Agreement with Ryan Network for Beta Test of United's HemoStyp(TM) Wound Care Product
Business Wire - Thu Feb 14, 9:30AM CST
United Health Products, Inc.'s www.unitedhealthproductsinc.com (OTCQB: UEEC.PK) wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp(TM). Under the beta test protocol, the HemoStyp(TM) gauze will be indicated for patients post venipuncture to assess expedited coagulation, ease of use, patient satisfaction, and decrease prolonged coagulation due to patients co-morbidities and anticoagulation therapy. The Ryan Network was founded upon former Congressman William F. Ryan's belief that "health care is a right, not a privilege." Ryan Network is a family of not-for-profit, federally qualified health centers with multiple locations in New York Ci
United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp(TM) Featured in Dentistry Today
Business Wire - Tue Jan 22, 10:43AM CST
United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp(TM), has been featured in the January 2013 edition of Dentistry Today. The article states that while there are other "hemostatic agents available to the dental practitioner, most of them are difficult to place, difficult to keep in position, and difficult to remove without disturbing the clotted surface, thereby reinitiating the bleeding. This specifically formulated gauze produces hemostasis almost instantly when positioned on a cut or wound. It contains no potentially harmful chemicals such as thrombin, collagen, or animal byproducts, is hypoallergenic, and works more quickly than other hemostatic agents. Once i
United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp(TM) Listed by Industry Publication Among the "Best Products Evaluated During 2012"; United Health Products Adds New Member to Board of Directors
Business Wire - Wed Dec 19, 12:21PM CST
United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp(TM), has been featured in the Clinicians Report(R) for the second time this year. The report is a published scientific testimonial that features products which have met the criteria and approval of the dental community. The Clinicians Report(R) is a 35-year-old industry publication serving as an informative tool to the dental industry with distribution to over 10,000 dental care providers. It features new products with published test results that have been tested and approved by dentists and the dental community. In the December issue HemoStyp(TM) was listed among the "Best Products Evaluated During 2012" with 83%
